CIK 0001810182
- Non-accelerated filer
- Smaller reporting company
ALX ONCOLOGY HOLDINGS INC
Sign in to watch- Ticker
- ALXO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 850642577
- Phone
- +1 650-466-7125
- Business address
- 323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Medical Officer acquired 37,000 shares (grant or award)
- 4 Grant or award VP, Finance and CAO acquired 11,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 29,000 shares (grant or award)
- 4 Grant or award President & CEO acquired 74,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Chief Financial Officer acquired 15,000 shares (option exercise)
- 4 Exercise or conversion President & CEO acquired 24,154 shares (option exercise)
- 4 Grant or award VP, Finance and CAO acquired 50,000 shares (grant or award)
- 4 Exercise or conversion Chief Medical Officer acquired 23,852 shares (option exercise)
- 4 Open-market sale Director sold 325,377 shares at an average $27.36 ($8,901,804)
- 4 Open-market sale 10% owner sold 48,390 shares at an average $26.61 ($1,287,431)
- 4 Open-market sale Director sold 145,637 shares at an average $32.26 ($4,698,091)
Page 7 of 11 · 213 filings